Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aukrust

Showing results (491-500 of 910) with videos related to

Pageof 91
Sort By:
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|February 26, 2013
Pentraxin 3, a novel cardiovascular biomarker, is expressed in aortic specimens of patients with coronary artery disease with and without rheumatoid arthritisIvana Hollan, Manuela Nebuloni, Barbara Bottazzi, et al.
International Journal of Cardiology|May 25, 2012
Disturbed carnitine regulation in chronic heart failure--increased plasma levels of palmitoyl-carnitine are associated with poor prognosisThor Ueland, Asbjørn Svardal, Erik Øie, et al.
Rheumatology (Oxford, England)|March 17, 2010
Inflammatory markers in patients with coronary artery disease with and without inflammatory rheumatic diseaseUnni M Breland, Ivana Hollan, Kjell Saatvedt, et al.
BMC Cancer|January 8, 2010
Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumorsDeidi Strickland Bergestuen, Jørgen Gravning, Kristina Hermann Haugaa, et al.
Blood|June 23, 2021
Combined effects of plasma von Willebrand factor and platelet measures on the risk of incident venous thromboembolismMagnus S Edvardsen, Ellen-Sofie Hansen, Kristian Hindberg, et al.
Atherosclerosis|June 9, 2014
Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature reviewIngunn Narverud, Kjetil Retterstøl, Per Ole Iversen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 28, 2009
Osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993-2003Anne G Semb, Thor Ueland, Pål Aukrust, et al.
Atherosclerosis|April 25, 2024
Gene expression profiling in elderly patients with familial hypercholesterolemia with and without coronary heart diseaseTorunn Melnes, Martin P Bogsrud, Jacob J Christensen, et al.
Thrombosis and Haemostasis|December 8, 2004
Effect of activated platelets on expression of cytokines in peripheral blood mononuclear cells - potential role of prostaglandin E2Torgun Waehre, Jan Kristian Damås, Arne Yndestad, et al.
American Journal of Preventive Cardiology|April 18, 2025
LDL cholesterol burden in elderly patients with familial hypercholesterolemia: Insights from real-world dataTorunn Melnes, Martin P Bogsrud, Jacob J Christensen, et al.
Pageof 91

Showing results (491-500 of 910) with videos related to

Sort By:
Pageof 91
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|February 26, 2013
Pentraxin 3, a novel cardiovascular biomarker, is expressed in aortic specimens of patients with coronary artery disease with and without rheumatoid arthritisIvana Hollan, Manuela Nebuloni, Barbara Bottazzi, et al.
International Journal of Cardiology|May 25, 2012
Disturbed carnitine regulation in chronic heart failure--increased plasma levels of palmitoyl-carnitine are associated with poor prognosisThor Ueland, Asbjørn Svardal, Erik Øie, et al.
Rheumatology (Oxford, England)|March 17, 2010
Inflammatory markers in patients with coronary artery disease with and without inflammatory rheumatic diseaseUnni M Breland, Ivana Hollan, Kjell Saatvedt, et al.
BMC Cancer|January 8, 2010
Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumorsDeidi Strickland Bergestuen, Jørgen Gravning, Kristina Hermann Haugaa, et al.
Blood|June 23, 2021
Combined effects of plasma von Willebrand factor and platelet measures on the risk of incident venous thromboembolismMagnus S Edvardsen, Ellen-Sofie Hansen, Kristian Hindberg, et al.
Atherosclerosis|June 9, 2014
Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature reviewIngunn Narverud, Kjetil Retterstøl, Per Ole Iversen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 28, 2009
Osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993-2003Anne G Semb, Thor Ueland, Pål Aukrust, et al.
Atherosclerosis|April 25, 2024
Gene expression profiling in elderly patients with familial hypercholesterolemia with and without coronary heart diseaseTorunn Melnes, Martin P Bogsrud, Jacob J Christensen, et al.
Thrombosis and Haemostasis|December 8, 2004
Effect of activated platelets on expression of cytokines in peripheral blood mononuclear cells - potential role of prostaglandin E2Torgun Waehre, Jan Kristian Damås, Arne Yndestad, et al.
American Journal of Preventive Cardiology|April 18, 2025
LDL cholesterol burden in elderly patients with familial hypercholesterolemia: Insights from real-world dataTorunn Melnes, Martin P Bogsrud, Jacob J Christensen, et al.
Pageof 91